Meanwhile, overexpression of ZG16 in colon cancer cells significantly influences the expression of both stimulatory and inhibitory checkpoint molecules, including CD40, PD1, and CTLA4 (18), promotes the secretion of pro-inflammatory mediators, and enhances T-cell-dependent antitumor effects (19). The gene discussed is ZG16; the disease is malignant colon neoplasm.